EXIST Transfer of Research (EXIST-Forschungstransfer)
Administered by Federal Ministry for Economic Affairs and Energy (BMWE), administered by Project Management Jülich
About this grant
Two-phase funding for outstanding, development-intensive research-based startup projects from universities and research institutions. Phase I (18 months): up to 4 full-time positions plus material costs up to €250K to prove technical feasibility, build prototypes and prepare the business plan and company formation. Phase II (18 months): up to €180K (maximum 75% of costs) for development to market maturity after founding. Applications can be submitted at any time; review and assessment start on 31 March, 31 August and 30 November each year.
Key facts
Eligibility requirements
All of the following criteria must be met:
- Phase I: founding teams from higher education or research institutions (up to 4 full-time equivalents, including at least one business-administration position); applied for by the university/research institution
- Phase II: companies founded during Phase I (including, under a model project, AI-core companies arising from the EXIST Startup Grant); applied for by the company
- A mentor from the higher education/research institution is required
- Projects must be outstanding, research-based and development-intensive, with startup potential
Application tips
Grant details are sourced from official public databases and reviewed weekly. Eligibility criteria, funding amounts, and deadlines may change without notice. Always confirm details on the Federal Ministry for Economic Affairs and Energy (BMWE), administered by Project Management Jülich website before applying.
Ready to put this grant to work?
Raftlabs helps established businesses turn funding into working software, loyalty apps, and AI tools.
Talk to Raftlabs →Other grants in Germany
More funding opportunities that may match your business
Detection of illicit trade
NPO
Detection of illicit trade
Towards a European production of stable isotopes for novel nuclear medicine therapies (SAMIRA/ERVI)
NPO
Towards a European production of stable isotopes for novel nuclear medicine therapies (SAMIRA/ERVI)
Apply Now: Thematic Area 4 Coordination and Support Action
USDA
Apply Now: Thematic Area 4 Coordination and Support Action